Bilamin comes as a oral solution with 12.5 mg/5 ml of Bilastine, from Ibn Sina Pharmaceuticals Ltd. Allergic rhino-conjunctivitis can cause sneezing, runny or blocked nose, and itchy or watery eyes.
There are 82 brands of Bilastine listed in Bangladesh. 57 of them have a lower unit price than Bilamin. The lowest listed price is Blastine 20 mg Tablet at ৳ 10 per unit.
What is Bilamin 12.5 mg/5 ml Oral Solution?
The oral solution Bilamin contains Bilastine and is made by Ibn Sina Pharmaceuticals Ltd. By blocking its action, Bilastine helps reduce these symptoms. It is used for symptomatic treatment of allergic rhino-conjunctivitis, both seasonal and perennial, and urticaria. The doctor decides whether it suits you and how it should be taken.
Uses of Bilamin
Allergic rhino-conjunctivitis can cause sneezing, runny or blocked nose, and itchy or watery eyes. Ask the doctor or pharmacist if you are unsure what this medicine is for or whether it is suitable for your condition. Bilamin oral solution is used for the symptomatic treatment of allergic rhino-conjunctivitis, which may be seasonal or perennial, and for urticaria. Your doctor will decide if it is suitable for you.
How to use Bilamin
Take Bilamin exactly as the doctor tells you. Complete the course exactly as prescribed. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Bilamin
Contact the doctor if a side effect is troublesome, does not go away, or if your child seems unwell. Anyone who notices a side effect or feels unwell while taking Bilamin should tell their doctor or pharmacist, especially if it continues or worries them. In clinical trials, the most commonly reported side effects were headache, dizziness, somnolence and fatigue. Contact your doctor promptly if a side effect worries you, does not settle, or seems to be getting worse. Tell your doctor if you notice any of these or any other unusual effect.
Safety and precautions
As a precautionary measure, it is preferable to avoid the use of Bilastine during pregnancy. The excretion of Bilastine in milk has not been studied in humans. Ketoconazole, Erythromycin, Cyclosporine, Ritonavir or Diltiazem) should be avoided in patients with moderate or severe renal impairment. Keep out of reach of children.
Frequently asked questions
What does Bilamin treat?
Allergic rhino-conjunctivitis can cause sneezing, runny or blocked nose, and itchy or watery eyes. Ask the doctor or pharmacist if you are unsure what this medicine is for or whether it is suitable for your condition.
How should I take Bilamin?
Take Bilamin exactly as the doctor tells you. Complete the course exactly as prescribed.
Can Bilamin cause side effects?
Contact the doctor if a side effect is troublesome, does not go away, or if your child seems unwell. Anyone who notices a side effect or feels unwell while taking Bilamin should tell their doctor or pharmacist, especially if it continues or worries them.
Bilastine is indicated for symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.
Pharmacology
Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral H 1 receptor antagonist affinity and no affinity for muscarinic receptors. Bilastine inhibits histamine-induced wheal and flare skin reactions for 24 hours following single doses.
Dosage & Administration
Adults & adolescents (12 years of age and over): 20 mg tablet once daily for symptomatic relief of allergic rhinitis, urticaria and allergic rhinoconjunctivitis. The maximum recommended daily dose is 20 mg Bilastine (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken. 20 mg Bilastine tablet (1 tablet) once daily should be swallowed with water on an empty stomach to achieve optimal exposure to Bilastine.
Children between 6 to 11 years: 10 mg mouth dissolving tablet for the symptomatic relief of allergic rhinitis, allergic rhinoconjunctivitis and urticaria. The Mouth dissolving tablet is for oral use only. It should be placed in the mouth. It will disperse rapidly in saliva and can be easily swallowed. Alternatively, the mouth dissolving tablet can be dispersed in a tea spoon of water before being swallowed by the children. The maximum recommended daily dose for children in between 6 to 11 years is 10 mg Bilastine mouth dissolving tablet (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken.
Children between 2 to 11 years: 4 ml once daily.
Interaction
Concomitant intake of Bilastine and Ketoconazole or Erythromycin or Diltiazem increased C max of Bilastine. The psychomotor performance after concomitant intake of alcohol and Bilastine was similar to that observed after intake of alcohol and placebo. Concomitant intake of Bilastine and Lorazepam 3 mg for 8 days did not potentiate the depressant CNS effects of Lorazepam.
Contraindications
Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet.
Side Effects
The most commonly reported side effects in clinical trial are headache, dizziness, somnolence and fatigue. These adverse events occurred with a comparable frequency in patients receiving placebo.
Pregnancy & Lactation
There are no or limited amount of data from the use of Bilastine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, parturition or postnatal development. As a precautionary measure, it is preferable to avoid the use of Bilastine during pregnancy. The excretion of Bilastine in milk has not been studied in humans. A decision must be made taking into account the benefit of breast-feeding for the child and the benefit of Bilastine therapy for the mother.
Precautions & Warnings
Co-administration of Bilastine and P-glycoprotein inhibitors (e.g. Ketoconazole, Erythromycin, Cyclosporine, Ritonavir or Diltiazem) should be avoided in patients with moderate or severe renal impairment.
Overdose Effects
In clinical trials, after administration of Bilastine at doses 10 to 11 times the therapeutic dose (220 mg as single dose; or 200 mg/day for 7 days) frequency of treatment-emergent adverse events was two times higher than with placebo. The adverse reactions most frequently reported were dizziness, headache and nausea. No serious adverse events and no significant prolongation in the QTc interval were reported.
Storage Conditions
Keep below 30°C temperature, protected from light and moisture. Keep out of reach of children.
Alternative brands of Bilastine
Other brands with the same generic name, cheapest first.